Laza Medical, a California-based medtech company, is developing advanced technologies for the cath lab. GE HealthCare also participated in a previous financing round in 2023.
Delivery systems included in this recall should not be used to treat patients going forward. The FDA shared an early alert about the issue back in October.
The 2027 Medicare Physician Fee Schedule includes conversion factors lower than what CMS originally proposed. In addition, a controversial policy many cardiologists are required to participate in is still set to go live on Jan. 1.
Researchers tracked data from nearly 6,000 patients being seen for suspected atrial fibrillation, coronary artery disease or heart failure. These data suggest patients can feel at ease meeting their cardiologist for the first time by video or telephone.
In terms of the study's primary endpoint, using CCTA to guide procedures was noninferior to IVUS. CCTA was also linked to certain advantages over IVUS, including improved cath lab efficiency.
A new-look cerebral embolic protection device for TAVR is safe to use and consistently captures debris. According to late-breaking data presented at TCT 2026, however, the device failed to demonstrate any tangible clinical benefits.
Traditionally, the interventional cardiologist first visualizes the coronary anatomy in detail when contrast is injected in the catheterization laboratory. For many patients, however, that anatomy has already been captured, often in considerable detail, by coronary CT angiography (CCTA) performed earlier in the clinical pathway. This article considers how this dataset can be used to plan the procedure, an approach referred to as CT-guided PCI.
